Eco R1 Capital, LLC Spring Works Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $83.4 Million - $137 Million	3,460,208 New	3,460,208 $98.7 Million
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $5.98 Million - $19.6 Million	-325,881 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $16 Million - $21.3 Million	325,881 New	325,881 $18.4 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.